NMN
Also known as: Nicotinamide Mononucleotide, Beta-NMN
NAD+ Precursor | Cellular Energy & Longevity
Overview
Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide and a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular energy metabolism, DNA repair, sirtuin activation, and hundreds of enzymatic reactions. NAD+ levels decline significantly with age, and this decline is implicated in mitochondrial dysfunction, genomic instability, and many hallmarks of aging. NMN supplementation aims to restore NAD+ levels by providing the immediate substrate for the enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT), which catalyzes the final step of NAD+ biosynthesis in the salvage pathway. Popularized by Harvard geneticist David Sinclair, NMN has become one of the most widely studied and used longevity supplements. While animal data is extensive and compelling, human clinical trial data is still accumulating, with several trials showing increases in blood NAD+ levels and improvements in various biomarkers of aging.
Key benefits
- Increases blood and tissue NAD+ levels, counteracting age-related decline
- Supports mitochondrial function and cellular energy production
- Activates sirtuin pathways involved in DNA repair and longevity
- May improve insulin sensitivity and glucose metabolism
- Supports cardiovascular function and vascular health
- May enhance exercise capacity and muscle endurance
- Promotes healthy aging at the cellular level
- Supports cognitive function and neuroprotection
Mechanism of action
NMN is converted to NAD+ via the NAD+ salvage pathway. After oral ingestion, NMN is absorbed in the gut, where it may be partially converted to nicotinamide riboside (NR) by the enzyme CD73 for cellular uptake, then re-phosphorylated intracellularly back to NMN. The enzyme NMNAT then converts NMN to NAD+. The resulting increase in NAD+ levels activates multiple longevity-associated pathways: sirtuins (SIRT1-7), a family of NAD+-dependent deacetylases that regulate mitochondrial biogenesis, DNA repair, inflammation, and stress resistance; PARP enzymes involved in DNA damage repair; and CD38/CD157 involved in immune cell signaling. By restoring NAD+ pools, NMN supplementation supports mitochondrial electron transport chain function and ATP production, enhances oxidative metabolism in skeletal muscle, and may counteract age-related metabolic decline. In the Slc12a8 transporter discovery, a dedicated NMN transporter was identified in the small intestine, supporting direct NMN absorption without prior conversion to NR.
Molecular data
- Type
- Nucleotide (C11H15N2O8P)
- Half-life
- ~2-3 hours (oral)
Indications
What the research community uses this compound for, with self-reported effectiveness.
Longevity / Anti-Aging
Metabolic Health
Physical Performance
Cardiovascular
Neurological
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Delivery method
| Protocol | Dose | Frequency | Duration |
|---|---|---|---|
| — | 250-500 mg/day | Once daily, morning | — |
| — | 500-1000 mg/day | Once or twice daily | — |
Delivery method
| Protocol | Dose | Frequency | Duration |
|---|---|---|---|
| — | 250-500 mg/day | Once daily, morning | — |
Protocol variations
Alternative cycling patterns reported in the literature and community.
Sinclair Protocol
David Sinclair, a prominent aging researcher at Harvard, has publicly shared his personal supplementation regimen which centers on NMN as the primary NAD+ precursor. He combines NMN with resveratrol (a sirtuin activator) and other longevity compounds. His rationale is that NMN provides the NAD+ fuel while resveratrol steps on the sirtuin accelerator, creating synergistic activation of longevity pathways.
Conservative Longevity Protocol
This protocol uses the dose range most commonly studied in published human clinical trials (250-500 mg/day). Multiple randomized controlled trials have demonstrated safety and NAD+ elevation at these doses with minimal side effects. Suitable for individuals who prefer to stay within the bounds of peer-reviewed clinical evidence.
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Mild gastrointestinal discomfort (nausea, bloating, diarrhea) at higher doses
- Flushing or warmth, particularly at doses above 500 mg
- Mild headache during initial supplementation period
- Increased energy that may affect sleep if taken too late in the day
Rare side effects
- Skin itching or mild rash
- Elevated homocysteine levels with long-term use (theoretical concern shared with other NAM-derived compounds)
- Gastrointestinal cramping at very high doses (above 1200 mg)
Contraindications
- Known hypersensitivity to nicotinamide mononucleotide or related compounds
- Active cancer (theoretical concern: NAD+ supports rapidly dividing cells; consult oncologist)
- Pregnancy or breastfeeding (insufficient safety data)
- Severe hepatic impairment (altered NAD+ metabolism)
Monitoring
- Blood NAD+ levels (if testing is available) at baseline and after 4-8 weeks
- Fasting glucose and insulin: baseline and every 3-6 months
- Complete metabolic panel: baseline and every 6-12 months
- Homocysteine levels: baseline and annually with long-term use
- Liver function tests: baseline and periodically if taking high doses
References
Primary literature and clinical-trial data informing this entry.